Addiction is not simply a chronic brain disease and considering it as such can limit treatment options and increase stigma, an extensive research review suggests.
WearLinq Acquires AMI Cardiac Monitoring, Raises $6.7M for FDA 510(k) Cleared 6-Lead ECG Device
What You Should Know: – WearLinq, a leader in wearable health monitoring, announced a strategic acquisition of AMI Cardiac Monitoring, LLC, a seasoned player in
May 22, 2024